Gene · 5266
Papers4,558
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,558
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer. | J Exp Clin Cancer Res | 2023 | 38102637 | PubTator, text mining | PubMed |
| A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia. | Front Cardiovasc Med | 2023 | 38099221 | PubTator, text mining | PubMed |
| Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation. | Mol Cancer | 2023 | 38093288 | PubTator, text mining | PubMed |
| COVID-19 and trained immunity: the inflammatory burden of long covid. | Front Immunol | 2023 | 38090572 | PubTator, text mining | PubMed |
| Acute lung injury caused by sepsis: how does it happen? | Front Med (Lausanne) | 2023 | 38076268 | PubTator, text mining | PubMed |
| The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects. | Nutrients | 2023 | 38068715 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review. | Cancers (Basel) | 2023 | 38067304 | PubTator, text mining | PubMed |
| Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases. | Behav Neurol | 2023 | 38058356 | PubTator, text mining | PubMed |
| Hsa_circ_0124554 may serve as a biomarker for the diagnosis of colorectal cancer: An observational study. | Medicine (Baltimore) | 2023 | 38050241 | PubTator, text mining | PubMed |
| Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). | Front Genet | 2023 | 38028629 | PubTator, text mining | PubMed |
| Revolutionizing orofacial pain management: the promising potential of stem cell therapy. | Front Pain Res (Lausanne) | 2023 | 38028430 | PubTator, text mining | PubMed |
A Reverse Shoulder Arthroplasty Implantation With Custom-Made Humerus and Intraoperative GPS Navigation in a Rare Case of Unilateral Hip and Shoulder Dysplasia Associated With a Bone Marrow Mosaic PTEN Truncating Variant: Case Report. | J Shoulder Elb Arthroplast | 2023 | 38021086 | PubTator, text mining | PubMed |
| The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial. | BMC Nutr | 2023 | 38012749 | PubTator, text mining | PubMed |
| The effects of ARID1A mutation in gastric cancer and its significance for treatment. | Cancer Cell Int | 2023 | 38008753 | PubTator, text mining | PubMed |
| An Integrative Approach to the Current Treatment of HIV-Associated Neurocognitive Disorders and the Implementation of Leukemia Inhibitor Factor as a Mediator of Neurocognitive Preservation. | Life (Basel) | 2023 | 38004334 | PubTator, text mining | PubMed |
| Inflammation and Psoriasis: A Comprehensive Review. | Int J Mol Sci | 2023 | 38003284 | PubTator, text mining | PubMed |
| HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article. | Int J Mol Sci | 2023 | 38003240 | PubTator, text mining | PubMed |
| Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target. | Respir Res | 2023 | 38001457 | PubTator, text mining | PubMed |
| Nerve Growth Factor and Autoimmune Diseases. | Curr Issues Mol Biol | 2023 | 37998739 | PubTator, text mining | PubMed |
| Caveolin-1: A Review of Intracellular Functions, Tissue-Specific Roles, and Epithelial Tight Junction Regulation. | Biology (Basel) | 2023 | 37998001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5266/papers?page=12